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Abstract 
A large part of the world is presently in the grip of the 
coronavirus disease (COVID-19) by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2 virus), 
declared a pandemic in March 2020. This document is a 
brief commentary of the imaging modalities used in the 
screening, diagnosis and management of COVID-19 
pneumonia. Chest x-rays, especially portable, still form a 
part of majority of official guidelines, with reports of the 
suggestive radiologic features. The potential of CT scan 
and ultrasound is also realised, with earlier detection rate. 
Typical radiologic findings of bilateral, asymmetrical, 
crazy-paved ground glass opacification, consolidation, 
reverse halo sign, opacities, progressing to fibrosis are 
well described for both the X-ray and CT scan. Atypical 
findings include airway changes, pleural effusion, 
pulmonary nodules and acute pulmonary embolism. 
Absence of lymphadenopathy, pleural effusion and 
pneumothorax is notable. The role of portable lung 
ultrasound, reported to be useful in emergency, is yet to 
be established in the guidelines. Disinfection of the 
equipment is a major concern. Governmental guidelines 
still advocate X-ray despite professional societies 
increasingly recommending CT scan. 
Keywords: COVID-19, Radiology, Chest X-ray, CT scan, 
Ultrasound, Artificial intelligence, Sub-pleural 
consolidation, Ground glass opacification. 
DOI: https://doi.org/10.5455/JPMA.21 
Introduction 
Viruses have been known to cause severe respiratory 
disease. The rise of Coronaviridae, considered a minor 
pathogen a few decades ago, to a feared name is 
astounding. Severe acute respiratory syndrome (SARS) 
epidemic surfaced in the early 2000, followed by Middle 
East respiratory syndrome (MERS), has now been 
toppled over by the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV- 2). The pandemic which first 
surfaced in China, spread to Europe, central Asia and the 
Americas and the rest of the world, mutating along the 
way becoming deadlier at some places and running 
relatively less aggressive course at others. The 
symptoms are non-specific; clinical course is not 
following any reliably predictable or defined pattern 
varying from asymptomatic carrier status, to mild flu-like 
to a severe pneumonia. Nucleic acid testing availability 
is falling short of the affected numbers. To top it all, the 
other respiratory pathogens have not declined, 
producing a dire need to differentiate between the 
COVID and non-COVID pulmonary disease. Imaging may 
play a role here. 
Reports of radiology features started appearing as early as 
January 2020, less than a month after disease emergence. 
Radiologically documented severe pneumonia was 
described, combined with respiratory distress, cardiac 
injury and other features of acute systemic injury.1 Since 
then, there is a growing body of evidence regarding the 
imaging of pulmonary damage on chest X-ray, CT scan, 
and lately ultrasound.2-8 
Radiologic Signs 
The chest X-ray and CT scan signs correspond with each 
other (Figures 1-4). The signs reported in literature can 
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Figure-1: Initial chest X-ray of a polymerase chain reaction coronavirus disease-
positive adult showing peripheral ground glass haze (arrows). 
(Image courtesy: Dr Imran Sharief, MD, FCCP).
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now be easily described as typical and atypical. 
Typical and common suggestive signs include:2-7 
u Ground glass haze (air-space opacification without 
obscuring vascular and interstitial markings) progressing to 
consolidation (air space opacification with air bronchogram, 
and obscured vascular and interstitial marking) 
u Reticular pattern with interstitial thickening of 
interstitial pneumonia 
u Dilated vessels and bronchi/airway disease within the 
lesions6,7 
u Reverse halo sign.4 
Atypical/ uncommon signs include: 
u Centrilobular nodules5,6 
u Fibrosis6 
u Pleural effusion3,6 
u Acute pulmonary embolism9 
u Lymphadenopathy is typically absent.2,3,6,7 
Distribution and Evolution of the Signs are 
the Distinctive Features 
It must be remembered that the above stated common or 
suggestive signs are actually non-specific per se, and only 
indicate acute lung injury as in organising pneumonias of 
any aetiology. The real distinctive feature is their 
distribution. The distribution is: 
u Sub-pleural -often described as peripheral but it can 
very well be central under mediastinal pleural reflections 
(Figure-4) 
Figure-2: A more advanced pulmonary disease with chest x-ray image with 
combination of ground glass pattern (arrow), foci of consolidation, interstitial 
thickening and occasional dilated bronchi. The involvement is bilateral, asymmetrical 
and more pronounced peripherally. 
(Image courtesy: Dr Imran Sharief, MD, FCCP).
Figure-3: Corresponding CT chest taken at the level of lower lobes, showing the 
combination of non-dependent ground glass pattern, foci of consolidation with air 
bronchogram (arrow), interstitial thickening and occasional dilated bronchi (circle). 
The involvement is bilateral, asymmetrical, with multi-segmental to lobar distribution 
and the epicenter is sub-pleural. 
(Image courtesy: Dr Imran Sharief, MD, FCCP)
Figure-4: Early changes of coronavirus disease (COVID-19) pulmonary disease; CT 
section at the level of carina, showing bilateral sub-pleural ground glass haze, with 
sub-segmental distribution. There is interstitial thickening with relatively prominent 
vessels (arrow). 
(Image courtesy: Dr Imran Sharief , MD, FCCP)
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u Bilateral but usually asymmetrical involvement,  
u Subsegmental to begin with, progressing to involve 
segments and lobes, and sometimes the whole lungs 
giving a white-washed appearance (Figures-2 and 3) 
u Lower lobar initially, ascending higher peripherally. 
This evolution pattern has been utilised to monitor, 
gauge the severity, and follow-up on sequential 
imaging.10 Using the same evolution pattern, Pan et al 
developed objective criteria for quantitative assessment 
of the pulmonary involvement.11 It evaluated serial CT 
scans to observe the topographic spread from segments 
to lobes to whole lungs, score staring from 0 (no 
segmental involvement) to a maximum of 25 (all 
segments involved).11 The original version included only 
segmental and lobar topography, while Huang et al 
improvised it to include the radiographic patterns as 
well, to consider the changes in CT appearances from 
simple ground glass opacification to crazy-paving, and 
frank consolidation.12 They also found that serial CT not 
only monitored the progress, but also noted that all 
recovered and discharged patients had residual 
radiologic signs despite clinical recovery, and PCR- 
negative status.12 
It was based on these predictive patterns that machine 
based models were developed and artificial intelligence 
was employed to differentiate COVID-19 pneumonia from 
the non- COVID community-acquired pneumonia on 
chest CT with 90 % sensitivity, and 96% specificity 
(p<0.001).13 
Role of Ultrasound 
Since the beginning of the pandemic, emergency and 
critical care clinicians, realising the need for urgent 
decision-making, have been stressing on the need to 
utilise the ultrasound for evaluation of consolidation 
and differentiation from pleural effusion based on the 
development of B-lines in a zone and of air 
bronchogram.8,14 Three or more B-lines per zone 
indicate positive zones and the presence and size of 
sub-pleural consolidation shows the extent of 
damage.8,14 While it makes sense for the sub-pleural 
and peripheral location of the nature of disease, deep- 
seated lesions, operator variability, disinfection of the 
equipment for an appropriate length of time, and 
physical proximity of the operator with the patient are 
practical hindrances. 
Present Situation and Utility 
X-rays are about 69% sensitive for diagnosis compared 
to > 90 % sensitivity of CT.3,9 A lot depends upon the 
interval between the appearance of symptoms and the 
patient's presentation to the healthcare facility. Early 
disease may be missed by X-ray but picked by CT; 
however CT is not available everywhere and is definitely 
more of a risk for cross-infection compared to a portable 
X-ray device. Hence governmental guidelines suggest 
the use of chest X-rays while national and international 
societies are encouraging the use of CT scan with 
development of scenario and resource-based protocols 
for optimum to best practices. Unless there are a greater 
number of dedicated CT scans, public hospitals in 
Pakistan are more likely to rely on chest X-ray for 
differentiation of COVID-19 pneumonia from other 
causes of pulmonary morbidity. Portable X-ray and 
ultrasound equipment are to be preferred for early 
results, limiting the spread of infection and ease of 
disinfection. 
Conclusion 
Radiology is helpful in monitoring the progression of 
COVID-19 pneumonia, with distinctive radiological 
patterns seen on chest X-ray and CT scan. Use of imaging 
should be guided by the clinical needs. Disinfection of the 
contaminated equipment and ease of availability desires 
the use of portable equipment. 
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